Apellis Pharmaceuticals Inc
NASDAQ:APLS

Watchlist Manager

Apellis Pharmaceuticals Inc

NASDAQ:APLS

Watchlist

Dividends

Price: 17.67 USD -0.51%

Market Cap: 2.2B USD

Activate Unlimited Plan
to continue APLS research

You've reached your weekly stock limit.

14-day money-back guarantee

Have any thoughts about
Apellis Pharmaceuticals Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 17.67 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

APLS Alert

Apellis Pharmaceuticals Inc

17.67

-0.09 (-0.51%)

52 Week Range	16.36 41.52
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Apellis Pharmaceuticals Inc

What unique competitive advantages
does Apellis Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Apellis Pharmaceuticals Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Apellis Pharmaceuticals Inc.

What unique competitive advantages
does Apellis Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Apellis Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Apellis Pharmaceuticals Inc recently?

Summarize the latest earnings call
of Apellis Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Apellis Pharmaceuticals Inc.

Provide P/S
for Apellis Pharmaceuticals Inc.

Provide P/E
for Apellis Pharmaceuticals Inc.

Provide P/OCF
for Apellis Pharmaceuticals Inc.

Provide P/FCFE
for Apellis Pharmaceuticals Inc.

Provide P/B
for Apellis Pharmaceuticals Inc.

Provide EV/S
for Apellis Pharmaceuticals Inc.

Provide EV/GP
for Apellis Pharmaceuticals Inc.

Provide EV/EBITDA
for Apellis Pharmaceuticals Inc.

Provide EV/EBIT
for Apellis Pharmaceuticals Inc.

Provide EV/OCF
for Apellis Pharmaceuticals Inc.

Provide EV/FCFF
for Apellis Pharmaceuticals Inc.

Provide EV/IC
for Apellis Pharmaceuticals Inc.

Show me price targets
for Apellis Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Apellis Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Apellis Pharmaceuticals Inc?

What are the Net Income projections
for Apellis Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Apellis Pharmaceuticals Inc?

What are the EPS projections
for Apellis Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Apellis Pharmaceuticals Inc?

What are the EBIT projections
for Apellis Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Apellis Pharmaceuticals Inc?

Compare the revenue forecasts
for Apellis Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Apellis Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Apellis Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Apellis Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Apellis Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Apellis Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Apellis Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Apellis Pharmaceuticals Inc.

Provide ROE
for Apellis Pharmaceuticals Inc.

Provide ROA
for Apellis Pharmaceuticals Inc.

Provide ROIC
for Apellis Pharmaceuticals Inc.

Provide ROCE
for Apellis Pharmaceuticals Inc.

Provide Gross Margin
for Apellis Pharmaceuticals Inc.

Provide Operating Margin
for Apellis Pharmaceuticals Inc.

Provide Net Margin
for Apellis Pharmaceuticals Inc.

Provide FCF Margin
for Apellis Pharmaceuticals Inc.

Show all solvency ratios
for Apellis Pharmaceuticals Inc.

Provide D/E Ratio
for Apellis Pharmaceuticals Inc.

Provide D/A Ratio
for Apellis Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Apellis Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Apellis Pharmaceuticals Inc.

Provide Quick Ratio
for Apellis Pharmaceuticals Inc.

Provide Current Ratio
for Apellis Pharmaceuticals Inc.

Provide Cash Ratio
for Apellis Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Apellis Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Apellis Pharmaceuticals Inc?

What is the current Free Cash Flow
of Apellis Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Apellis Pharmaceuticals Inc.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

APLS Price Targets Summary
Apellis Pharmaceuticals Inc

Wall Street analysts forecast APLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for APLS is 36.08 USD with a low forecast of 18.18 USD and a high forecast of 63 USD.

APLS Average Forecast

Wall Street Target

36.08 USD

104% Upside

APLS Highest Forecast

Wall Street Target

63 USD

257% Upside

Lowest

Price Target

18.18 USD

3% Upside

Average

Price Target

36.08 USD

104% Upside

Highest

Price Target

63 USD

257% Upside

Apellis Pharmaceuticals Inc Competitors:
Price Targets

VNDA

Vanda Pharmaceuticals Inc

185% Upside

TNGX

Tango Therapeutics Inc

113% Upside

URGN

Urogen Pharma Ltd

140% Upside

CRNX

Crinetics Pharmaceuticals Inc

148% Upside

VNDA

Vanda Pharmaceuticals Inc

185% Upside

TNGX

Tango Therapeutics Inc

113% Upside

URGN

Urogen Pharma Ltd

140% Upside

CRNX

Crinetics Pharmaceuticals Inc

148% Upside

BBIO

BridgeBio Pharma Inc

53% Upside

AMGN

Amgen Inc

10% Upside

SYRE

Spyre Therapeutics Inc

268% Upside

OSE

OSE Immunotherapeutics SA

233% Upside

Revenue
Forecast

Revenue Estimate
Apellis Pharmaceuticals Inc

The compound annual growth rate of Apellis Pharmaceuticals Inc's revenue for the next 3 years is 15%.

N/A

Past Growth

15%

Estimated Growth

Estimates Accuracy

Average Miss

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Apellis Pharmaceuticals Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-2%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Apellis Pharmaceuticals Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-39%

Average Miss

What are analyst estimates?

What is APLS's stock price target?

Price Target
36.08 USD

According to Wall Street analysts, the average 1-year price target for APLS is 36.08 USD with a low forecast of 18.18 USD and a high forecast of 63 USD.

What is Apellis Pharmaceuticals Inc's Revenue forecast?

Projected CAGR
15%

The compound annual growth rate of Apellis Pharmaceuticals Inc's revenue for the next 3 years is 15%.

	Apellis Pharmaceuticals Inc NASDAQ:APLS	17.67 USD -0.51%
K	Kiwetinohk Energy Corp TSX:KEC	19.15 CAD 0.26%
	Nano One Materials Corp TSX:NANO	0.6 CAD
T	Telemedycyna Polska SA WSE:TMP	0.73 PLN -6.41%
	Bang & Olufsen A/S CSE:BO	12.6 DKK -3.08%
	Manulife Financial Corp TSX:MFC	42.36 CAD 0.59%

	Franklin Covey Co NYSE:FC	22.29 USD 0.13%
	Mohawk Industries Inc NYSE:MHK	99.41 USD 1.45%
	Ardmore Shipping Corp NYSE:ASC	10.225 USD -2.99%
	ASGN Inc NYSE:ASGN	49.165 USD -0.19%
	Skyworks Solutions Inc NASDAQ:SWKS	71.49 USD -0.18%
	Weatherford International PLC NASDAQ:WFRD	51.09 USD -0.18%

	Johnson & Johnson NYSE:JNJ	149.65 USD -0.72%
	Bank of America Corp NYSE:BAC	45.53 USD 1.04%
	Mastercard Inc NYSE:MA	536 USD -0.51%
	Salesforce Inc NYSE:CRM	262.04 USD 0.98%
	Abbvie Inc NYSE:ABBV	185.48 USD -0.01%
	Home Depot Inc NYSE:HD	350.03 USD 0.86%

	Arista Networks Inc NYSE:ANET	87.24 USD -3.32%
	Deckers Outdoor Corp NYSE:DECK	101.65 USD 0.64%
	Visa Inc NYSE:V	338.64 USD -0.51%
	Texas Pacific Land Corp NYSE:TPL	1 081.92 USD 0.2%
	KLA Corp NASDAQ:KLAC	846.835 USD -2.79%
	Manhattan Associates Inc NASDAQ:MANH	186.95 USD -0.82%

	Salesforce Inc NYSE:CRM	262.04 USD 0.98%
	Accenture PLC NYSE:ACN	287.08 USD -6.3%
	ServiceNow Inc NYSE:NOW	980.185 USD -0.19%
	Spotify Technology SA NYSE:SPOT	713.52 USD 0.47%
	EOG Resources Inc NYSE:EOG	124.84 USD 0.86%
	Applied Materials Inc NASDAQ:AMAT	168.63 USD -2.44%

Apellis Pharmaceuticals Inc
NASDAQ:APLS

Wall Street
Price Targets

APLS Price Targets Summary
Apellis Pharmaceuticals Inc

Revenue
Forecast

Revenue Estimate
Apellis Pharmaceuticals Inc

Operating Income
Forecast

Operating Income Estimate
Apellis Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Apellis Pharmaceuticals Inc

See Also

What is APLS's stock price target?

Price Target
36.08 USD

What is Apellis Pharmaceuticals Inc's Revenue forecast?

Projected CAGR
15%

Company

Help

Tools

Stocks

Apellis Pharmaceuticals Inc NASDAQ:APLS

Wall Street Price Targets

APLS Price Targets Summary Apellis Pharmaceuticals Inc

Revenue Forecast

Revenue Estimate Apellis Pharmaceuticals Inc

Operating Income Forecast

Operating Income Estimate Apellis Pharmaceuticals Inc

Net Income Forecast

Net Income Estimate Apellis Pharmaceuticals Inc

See Also

What is APLS's stock price target? Price Target 36.08 USD

What is Apellis Pharmaceuticals Inc's Revenue forecast? Projected CAGR 15%

Company

Help

Tools

Stocks

Apellis Pharmaceuticals Inc
NASDAQ:APLS

Wall Street
Price Targets

APLS Price Targets Summary
Apellis Pharmaceuticals Inc

Revenue
Forecast

Revenue Estimate
Apellis Pharmaceuticals Inc

Operating Income
Forecast

Operating Income Estimate
Apellis Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Apellis Pharmaceuticals Inc

What is APLS's stock price target?

Price Target
36.08 USD

What is Apellis Pharmaceuticals Inc's Revenue forecast?

Projected CAGR
15%